Indian Journal of Critical Care Case Report

Register      Login

VOLUME 2 , ISSUE 2 ( March-April, 2023 ) > List of Articles


Clinical Significance of Trichosporon in Urine of Immunocompromised Host

Sudipta Mukherjee, Pralay S Ghosh, Santanu Bagchi, Sanjay Bhattacharya

Keywords : Echocardiography, Immunocompromised host, Sepsis

Citation Information : Mukherjee S, Ghosh PS, Bagchi S, Bhattacharya S. Clinical Significance of Trichosporon in Urine of Immunocompromised Host. 2023; 2 (2):37-39.

DOI: 10.5005/jp-journals-11006-0044

License: CC BY-NC 4.0

Published Online: 06-05-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Yeasts such as Trichosporon are being increasingly reported in catheterized urine of hospitalized patients. However, guidelines to interpret their clinical significance are lacking. The following case highlights the need for research and evidence-based recommendations for the management of funguria, especially for Trichosporon in urine for critically ill patients with nonresolving sepsis. This is a case of metastatic carcinoma lung on immunotherapy, which developed nonresolving sepsis along with repeated isolation of Trichosporon from urine. Patient had shown clinical response only after treatment with voriconazole.

PDF Share
  1. Colombo AL, Padovan AC, Chaves GM. Current knowledge of trichosporon spp. and trichosporonosis. Clin Microbiol Rev 2011;24(4):682–700. DOI: 10.1128/CMR.00003-11
  2. Kauffman CA. Candiduria. Clin Infect Dis 2005;41(6):S371–S376. DOI: 10.1086/430918
  3. Challapilla M, Patel K, Patel B, et al. Trichosporon–blood stream infection. J Assoc Physicians India 2019;67(3):19–21. PMID: 31304699.
  4. de Almeida Júnior JN, Hennequin C. Invasive trichosporon infection: a systematic review on a re-emerging fungal pathogen. Front Microbiol 2016;7:1629. DOI: 10.3389/fmicb.2016.01629
  5. Singh S, Capoor MR, Varshney S, et al. Epidemiology and antifungal susceptibility of infections caused by trichosporon species: an emerging non- candida and non- cryptococcus yeast worldwide. Indian J Med Microbiol 2019;37(4):536–541. DOI: 10.4103/ijmm.IJMM_19_146
  6. Sun W, Su J, Xu S, et al. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing. J Med Microbiol 2012;61(pt 12):1750–1757. DOI: 10.1099/jmm.0.049817-0
  7. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. invasive fungal infections cooperative group of the European organization for research and treatment of cancer and mycoses study group of the national institute of allergy and infectious diseases. Clin Infect Dis 2002;34(1):7–14. DOI: 10.1086/323335
  8. Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis 2020;71(6):1367–1376. DOI: 10.1093/cid/ciz1008
  9. Kontoyiannis DP, Torres HA, Chagua M, et al. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis 2004;36(8):564–569. DOI: 10.1080/00365540410017563
  10. Arendrup MC, Boekhout T, Akova M, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect 2014;20(Suppl 3):76–98. DOI: 10.1111/1469-0691.12360
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.